A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery

被引:277
|
作者
Kalaria, Piyush N. [1 ]
Karad, Sharad C. [2 ]
Raval, Dipak K. [1 ]
机构
[1] Sardar Patel Univ, Dept Chem, Vallabh Vidyanagar 388120, Gujarat, India
[2] Marwadi Univ, Dept Chem, Rajkot, Gujarat, India
关键词
Antimalarial; Malaria; Plasmodium; Heterocyclic; PARASITE PLASMODIUM-FALCIPARUM; BIOLOGICAL EVALUATION; ANTIPLASMODIAL ACTIVITY; POLYHYDROQUINOLINE DERIVATIVES; QUINAZOLINE DERIVATIVES; QUINOLINE ANTIMALARIALS; ANTILEISHMANIAL AGENTS; MITOCHONDRIAL-FUNCTION; LEAD OPTIMIZATION; HYBRID COMPOUNDS;
D O I
10.1016/j.ejmech.2018.08.040
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The upward extend of malaria collectively with the emergence of resistance against predictable drugs has put enormous pressure on public health systems to introduce new malaria treatments. Heterocycles play an important role in the design and discovery of new malaria active compounds. Heterocyclic compounds have attracted significant attention for malaria treatment because of simplicity of parallelization and the examining power with regard to chemical space. Introduction of a variety of heterocyclic compounds have enabled to maintain the high levels of antimalarial potency observed for other more lipophilic analogues whilst improving the solubility and the oral bioavailability in pre-clinical species. In this review, we present an overview of recent literature to provide imminent into the applications of different heterocyclic scaffolds in fighting against malaria. (C) 2018 Published by Elsevier Masson SAS.
引用
收藏
页码:917 / 936
页数:20
相关论文
共 50 条
  • [1] Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review
    Qin, Hua-Li
    Zhang, Zai-Wei
    Lekkala, Ravindar
    Alsulami, Hamed
    Rakesh, K. P.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 193
  • [2] Diarylpentanoids, the privileged scaffolds in antimalarial and anti-infectives drug discovery: A review
    Ramli, Amirah H.
    Faudzi, Siti M. Mohd
    [J]. ARCHIV DER PHARMAZIE, 2023, 356 (12)
  • [3] A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors
    Rani, Sudesh
    Raheja, Konpal
    Luxami, Vijay
    Paul, Kamaldeep
    [J]. BIOORGANIC CHEMISTRY, 2021, 113
  • [4] Privileged heterocyclic scaffolds in chemical biology and drug discovery: synthesis and bioactivity
    [J]. Chemistry of Heterocyclic Compounds, 2017, 53 : 239 - 239
  • [5] Privileged heterocyclic scaffolds in chemical biology and drug discovery: synthesis and bioactivity
    Altomare, Cosimo Damiano
    [J]. CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2017, 53 (03) : 239 - 239
  • [6] Fluorinated scaffolds for antimalarial drug discovery
    Upadhyay, Charu
    Chaudhary, Monika
    De Oliveira, Ronaldo N.
    Borbas, Aniko
    Kempaiah, Prakasha
    Poonam
    Rathi, Brijesh
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (06) : 705 - 718
  • [7] Privileged scaffolds and frequent hitters in drug discovery
    Schneider, Petra
    Schneider, Gisbert
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [8] Privileged scaffolds for library design and drug discovery
    Welsch, Matthew E.
    Snyder, Scott A.
    Stockwell, Brent R.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (03) : 347 - 361
  • [9] Privileged Scaffolds in Natural Products and Drug Discovery
    Sun, Dianqing
    Guendisch, Daniela
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (11) : 1199 - 1199
  • [10] Pyrazole Bearing Pyrimidine Analogues as the Privileged Scaffolds in Antimicrobial Drug Discovery: A Review
    Trivedi, Harsh D.
    Joshi, Vidhi B.
    Patel, Bonny Y.
    [J]. ANALYTICAL CHEMISTRY LETTERS, 2022, 12 (02) : 147 - 173